Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases
Contract Overview
Contract Amount: $19,644,619 ($19.6M)
Contractor: Dynport Vaccine Company LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2008-05-30
End Date: 2018-09-30
Contract Duration: 3,775 days
Daily Burn Rate: $5.2K/day
Official Description: PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES
Place of Performance
Location: Maryland, 21702
State: Maryland Government Spending